Kolexia
De Rauglaudre Gaetan Oncologie radiothérapie
De Rauglaudre Gaetan
Oncologie radiothérapie
Imag En Coupes Avig Vaucl Site Ste Cat
Avignon, France
50 Activités
541 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de l'ovaire Tumeurs du sein Carcinome épithélial de l'ovaire Fatigue Métastase tumorale Adénocarcinome Maladies du sein Néoplasmes unilatéraux du sein Maladie chronique

Collaborateurs

Voir plus
Grenier Julien
Grenier Julien
Institut Sainte Catherine, Avignon, France
Arnaud Antoine
Arnaud Antoine
Imag En Coupes Avig Vaucl Site Ste Cat, Avignon, France
Mege Alice
Mege Alice
Imag En Coupes Avig Vaucl Site Ste Cat, Avignon, France
Stancu Alma
Stancu Alma
Institut Sainte Catherine, Avignon, France

Industries

Voir plus
Lilly
4 collaboration(s)
Dernière en 2022
MSD
3 collaboration(s)
Dernière en 2023
Leo Pharma
1 collaboration(s)
Dernière en 2020
Pfizer
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
793P Strong relationships between the CA-125 KELIM score and the tumor biological effects after neo-adjuvant chemotherapy in advanced ovarian cancer patients: CHIVA trial (GINECO)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
CHIVA: Randomized Double Blind Placebo-controlled Phase II Trial of Vargatef® (Nintedanib) in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Adenocarcinoma of the Ovary, the Fallopian Tube or Serous Adenocarcinoma of the Peritoneum
Essai Clinique (ARCAGY/ GINECO GROUP)   05 septembre 2023
ABLE02: A National, Multicenter, Randomized Controlled Trial to Assess the Efficacy of a Physical Activity Program to Improve Quality of Life and Reduce Fatigue in Women With Metastatic Breast Cancer
Essai Clinique (Centre Léon-Bérard)   29 août 2023
Corrigendum to "A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer".
Gynecologic oncology   02 juin 2023
121TiP LESS: Single-arm study to de-escalate adjuvant endocrine therapy duration in post-menopausal women with HR+ HER2- early breast cancer at very low risk of metastasis
Abstract Book of ESMO Breast Cancer 2023, Berlin, Germany, 11-13 May 2023   01 mai 2023
A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer.
Gynecologic oncology   01 mars 2023
Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial.
Gynecologic oncology   25 janvier 2023
Needs assessment for the establishment of an Oral Therapy Unit.
Bulletin du cancer   18 novembre 2022
Immune tumor microenvironnement (iTME) post-neoadjuvant chemotherapy, beyond PD-L1: Novel immune targets in ovarian cancer, data from the CHIVA trial, a GINECO/GINEGEPS study.
2022 ASCO Annual Meeting I   02 juin 2022
Evaluation of a RAD51 functional assay in advanced ovarian cancer, a GINECO/GINEGEPS study.
2021 ASCO Annual Meeting I   28 mai 2021